Primary Biliary Cholangitis - 15 Studies Found
| Completed |
: MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension) : Primary Biliary Cirrhosis : 2016-11-02 :
|
| Completed |
: A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients : Primary Biliary Cholangitis : 2015-08-04 :
|
| Active, not recruiting |
: Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis : Primary Biliary Cirrhosis : 2015-12-19 |
| Not yet recruiting |
: A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS) : Primary Biliary Cirrhosis : 2017-04-10 :
|
| Completed |
: Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2008-12-08 :
|
| Completed |
: Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2015-09-21 : Dietary Supplement: S-adenosyl-L-methionine Patients will be treated with S-adenosyl-L-methionine, table |
| Completed |
: High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis : Primary Biliary Cirrhosis : 2012-05-17 : Dietary Supplement: High protein high fiber diet A personalized high protein high fiber dietary plan wil |
| NOT_YET_RECRUITING |
: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) : : 2025-08-02 : Oral QD |
| Completed |
: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis : Primary Biliary Cholangitis : 2025-08-02 : Seladelpar 10 mg one capsule daily for up to 36 months. |
| Completed |
: A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis : Primary Biliary Cholangitis (PBC) : 2025-08-02 : Duration: up to an estimated 84-month (7-year) double-blind treatment period during which elafibranor 80 mg tablet will be administered once daily |